Latest News about ABBV
Recent news which mentions ABBV
From Motley Fool
From Motley Fool
From Motley Fool
From Motley Fool
From Benzinga
For AbbVie’s blockbuster Humira, cheaper competitors pose surprisingly little threat, analysts say
June 30, 2023
From MarketWatch
Why Shares of Alvotech Are Jumping Friday
June 30, 2023
From Motley Fool
From InvestorPlace
Why This BeiGene Analyst Slashes Forecast By Almost 42%
June 30, 2023
From Benzinga
Bausch + Lomb Poised To Boost Presence In Growing Market With Potential $1.75B Drug Acquisition Deal From Novartis
June 30, 2023
From Benzinga
7 Best Dividend Stocks to Buy Now in July 2023
June 29, 2023
From Motley Fool
Why Are Immunome Shares Trading Higher Today
June 29, 2023
From Benzinga
5 High-Yielding Dividend Stocks That Are Bargain Buys
June 29, 2023
From Motley Fool
7 Top Growth Stocks to Watch for H2 2023
June 29, 2023
From InvestorPlace
From Benzinga
From MarketWatch
What Will AbbVie Buy Next?
June 28, 2023
From Motley Fool
Genmab/AbbVie's Blood Cancer Treatment Shows 82% Response Rate In Pretreated Follicular Lymphoma Patients
June 28, 2023
From Benzinga
7 Stocks That Every 40-Year-Old Should Buy Today
June 27, 2023
From InvestorPlace
Quant Ratings Updated on 90 Stocks
June 27, 2023
From InvestorPlace
From InvestorPlace
Why CollPlant Biotechnologies Stock Is Trading Higher
June 26, 2023
From Benzinga
Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts
June 26, 2023
From Benzinga
Tickers
ABBV
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|